My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 86

    1.

    Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study.

    Xanthopoulos A, Bauer TT, Blum TG, Kollmeier J, Schönfeld N, Serke M.

    J Occup Med Toxicol. 2008 Dec 18;3:34.PMID: 19091133 [PubMed - in process]Free PMC ArticleFree textRelated citations

    2.

    Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.

    Zucali PA, Ceresoli GL, Garassino I, De Vincenzo F, Cavina R, Campagnoli E, Cappuzzo F, Salamina S, Soto Parra HJ, Santoro A.

    Cancer. 2008 Apr 1;112(7):1555-61.PMID: 18286536 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    3.

    Assessment of Survival and Clinical Benefit in Malignant Pleural Mesothelioma (MPM) Patients Treated with Gemcitabine and Carboplatin.

    Ryad AY, Mostafa E, Salem DA, Al-Adwy ER, Margerges M.

    J Egypt Natl Canc Inst. 2007 Mar;19(1):61-70.PMID: 18839036 [PubMed - in process]Free ArticleRelated citations

    4.

    Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma.

    Jassem J, Ramlau R, Santoro A, Schuette W, Chemaissani A, Hong S, Blatter J, Adachi S, Hanauske A, Manegold C.

    J Clin Oncol. 2008 Apr 1;26(10):1698-704.PMID: 18375898 [PubMed - indexed for MEDLINE]Related citations

    5.

    Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.

    Simon GR, Verschraegen CF, Jänne PA, Langer CJ, Dowlati A, Gadgeel SM, Kelly K, Kalemkerian GP, Traynor AM, Peng G, Gill J, Obasaju CK, Kindler HL.

    J Clin Oncol. 2008 Jul 20;26(21):3567-72.PMID: 18640937 [PubMed - indexed for MEDLINE]Related citations

    6.

    Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study.

    Fizazi K, Doubre H, Le Chevalier T, Riviere A, Viala J, Daniel C, Robert L, Barthélemy P, Fandi A, Ruffié P.

    J Clin Oncol. 2003 Jan 15;21(2):349-54.PMID: 12525529 [PubMed - indexed for MEDLINE]Related citations

    7.

    Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.

    Jänne PA, Simon GR, Langer CJ, Taub RN, Dowlati A, Fidias P, Monberg M, Obasaju C, Kindler H.

    J Clin Oncol. 2008 Mar 20;26(9):1465-71.PMID: 18349397 [PubMed - indexed for MEDLINE]Related citations

    8.

    Gemcitabine and carboplatin treatment in patients with relapsing ovarian cancer.

    Sufliarsky J, Chovanec J, Svetlovska D, Minarik T, Packan T, Kroslakova D, Lalabova R, Helpianska L, Horvathova D, Sevcik L, Spacek J, Laluha A, Tkacova V, Malec V, Rakicka G, Magdin D, Jancokova I, Dorr A, Stresko M, Habetinek V, Koza I.

    Neoplasma. 2009;56(4):291-7.PMID: 19473054 [PubMed - indexed for MEDLINE]Related citations

    9.

    Single-agent pemetrexed for chemonaïve and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program.

    Taylor P, Castagneto B, Dark G, Marangolo M, Scagliotti GV, van Klaveren RJ, Labianca R, Serke M, Schuette W, van Meerbeeck JP, Heigener D, Liu Y, Adachi S, Blatter J, von Pawel J.

    J Thorac Oncol. 2008 Jul;3(7):764-71.PMID: 18594323 [PubMed - indexed for MEDLINE]Related citations

    10.

    A multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesothelioma.

    Schutte W, Blankenburg T, Lauerwald K, Schreiber J, Bork I, Wollscgkaeger B, Treutler D, Schneider CP, Bonner R.

    Clin Lung Cancer. 2003 Mar;4(5):294-7.PMID: 14609447 [PubMed]Free ArticleRelated citations

    11.

    Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma.

    Qin TJ, Zhao XH, Yun J, Zhang LX, Ruan ZP, Pan BR.

    World J Gastroenterol. 2008 Sep 7;14(33):5210-6.PMID: 18777599 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    12.

    Phase II Study of Gemcitabine Plus Docetaxel as Second-Line Treatment in Malignant Pleural Mesothelioma: A Single Institution Study.

    Tourkantonis I, Makrilia N, Ralli M, Alamara C, Nikolaidis I, Tsimpoukis S, Charpidou A, Kotanidou A, Syrigos K.

    Am J Clin Oncol. 2010 May 3. [Epub ahead of print]PMID: 20142722 [PubMed - as supplied by publisher]Related citations

    13.

    Pemetrexed maintenance therapy in patients with malignant pleural mesothelioma.

    van den Bogaert DP, Pouw EM, van Wijhe G, Vernhout RM, Surmont VF, Hoogsteden HC, van Klaveren RJ.

    J Thorac Oncol. 2006 Jan;1(1):25-30.PMID: 17409823 [PubMed - indexed for MEDLINE]Related citations

    14.

    Second-line treatment with a combination of continuous 5-fluorouracil, doxorubicin, and mitomycin-C (conti-FAM) in gemcitabine-pretreated pancreatic and biliary tract cancer.

    Lee S, Oh SY, Kim BG, Kwon HC, Kim SH, Rho MH, Kim YH, Rho MS, Jeong JS, Kim HJ.

    Am J Clin Oncol. 2009 Aug;32(4):348-52.PMID: 19363436 [PubMed - indexed for MEDLINE]Related citations

    15.

    Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma.

    Hollebecque A, Bouché O, Romano O, Scaglia E, Cattan S, Zerbib P, Heurgue A, Lagarde S, Mariette C, Triboulet JP, Pruvot FR, Hebbar M.

    Chemotherapy. 2010;56(3):234-8. Epub 2010 Jun 16.PMID: 20551640 [PubMed - in process]Related citations

    16.

    Cisplatin-Ifosfamide-gemcitabine as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and Paclitaxel.

    Polyzos A, Tsavaris N, Gogas H, Lagadas A, Polyzos K, Giannakopoulos K, Felekouras E, Tsigris C, Karatzas T, Papadopoulos O, Giannopoulos A.

    Anticancer Res. 2009 Jul;29(7):2681-6.PMID: 19596946 [PubMed - indexed for MEDLINE]Related citations

    17.

    Pemetrexed as second-line treatment in malignant pleural mesothelioma after platinum-based first-line treatment.

    Sørensen JB, Sundstrøm S, Perell K, Thielsen AK.

    J Thorac Oncol. 2007 Feb;2(2):147-52.PMID: 17410031 [PubMed - indexed for MEDLINE]Related citations

    18.

    Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.

    Lim JY, Cho JY, Oh KJ, Choi SH, Lee SI, Jeung HC.

    Chemotherapy. 2009;55(4):200-6. Epub 2009 May 19.PMID: 19451710 [PubMed - indexed for MEDLINE]Related citations

    19.

    Docetaxel plus gemcitabine as first-line treatment in malignant pleural mesothelioma: a single institution phase II study.

    Ralli M, Tourkantonis I, Makrilia N, Gkini E, Kotteas E, Gkiozos I, Katirtzoglou N, Syrigos K.

    Anticancer Res. 2009 Aug;29(8):3441-4.PMID: 19661370 [PubMed - indexed for MEDLINE]Related citations

    20.

    Non-Cross Resistant Sequential Single Agent Chemotherapy in First-Line Advanced Non-Small Cell Lung Cancer Patients: Results of a Phase II Study.

    Surmont V, Aerts JG, Tan KY, Schramel F, Vernhout R, Hoogsteden HC, van Klaveren RJ.

    J Oncol. 2009;2009:457418. Epub 2009 Nov 12.PMID: 19920864 [PubMed - in process]Free PMC ArticleFree textRelated citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    You are here: NCBI > Literature > PubMed
    Write to the Help Desk